Skip to Content

Poteligeo Prices, Coupons and Patient Assistance Programs

Poteligeo (mogamulizumab) is a member of the miscellaneous antineoplastics drug class and is commonly used for Mycosis Fungoides.

Poteligeo Prices

This Poteligeo price guide is based on using the discount card which is accepted at most U.S. pharmacies. The cost for Poteligeo intravenous solution (4 mg/mL) is around $4,026 for a supply of 5 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Intravenous Solution

4 mg/mL Poteligeo intravenous solution
from $4,025.61 for 5 milliliters
Quantity Per unit Price
5 milliliters $805.12 $4,025.61

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee. Printable Discount Card

Print Now

The free Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Poteligeo Coupons and Rebates

Poteligeo offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Poteligeo Co-Pay Assistance Program: Eligible commercially insured patients may receive co-pay assistance; for additional information contact the program at 833-552-2737.

Applies to:Poteligeo
Number of uses:Per prescription until program expires

Patient Assistance Programs for Poteligeo

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:

  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.

Applicable drugs:

  • Poteligeo (mogamulizumab-KPKC) Injection; IV

Provider: Kyowa Kirin Cares Patient Assistance Program (Poteligeo)

Elligibility requirements:

  1. Must be uninsured
  2. At or below 400% of FPL
  3. FDA-approved diagnosis
  4. The patient must also be permanently residing in the US or US territories.
  5. This program also provides copay assistance.

Applicable drugs:

  • Poteligeo (mogamulizumab-KPKC) Injection; IV